SCOPUS 정보 검색 플랫폼

Internal Medicine

Volumn 51, Issue 7, 2012, Pages 791-793

Coenzyme Q10 therapy in hereditary motor sensory neuropathy type VI with novel mitofusin 2 mutation

(5) Takahashi, Ryoichi a Ikeda, Tokuhei a Hamaguchi, Ayumi a Iwasa, Kazuo a Yamada, Masahito a

a KANAZAWA UNIVERSITY (Japan)

Author keywords

Coenzyme Q10; Hereditary motor sensory neuropathy type VI; MFN2; Polyneuropathy

Indexed keywords

LACTIC ACID; MITOFUSIN 2; PYRUVIC ACID; UBIDECARENONE;

ADULT; AEROBIC EXERCISE; ARTICLE; CASE REPORT; CENTRAL SCOTOMA; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA SEQUENCE; DRUG MEGADOSE; ELECTROPHYSIOLOGY; GENE MUTATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HEREDITARY MOTOR SENSORY NEUROPATHY TYPE VI; HUMAN; MALE; MUSCLE ACTION POTENTIAL; MUSCLE ATROPHY; MUSCLE WEAKNESS; NUCLEIC ACID BASE SUBSTITUTION; OPTIC NERVE ATROPHY; PERIMETRY; SENSORY DYSFUNCTION; TENDON REFLEX; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; AMINO ACID SUBSTITUTION; BASE SEQUENCE; CHARCOT-MARIE-TOOTH DISEASE; DNA MUTATIONAL ANALYSIS; GTP PHOSPHOHYDROLASES; HEREDITARY SENSORY AND MOTOR NEUROPATHY; HUMANS; MALE; MITOCHONDRIAL PROTEINS; MUTATION, MISSENSE; OPTIC ATROPHIES, HEREDITARY; UBIQUINONE; VISUAL ACUITY; VISUAL FIELDS;

EID: 84859337851 PISSN: 09182918 EISSN: 13497235 Source Type: Journal
DOI: 10.2169/internalmedicine.51.6676 Document Type: Article

Times cited : (16)

References (6)

1
- 32044474896
- Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2
- Züchner S, De Jonghe P, Jordanova A, et al. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. Ann Neurol 59: 276-281, 2006.
- (2006) Ann Neurol , vol.59 , pp. 276-281
- Züchner, S.¹ De Jonghe, P.² Jordanova, A.³

2
- 20444461625
- The Charcot-Marie-Tooth type 2 A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system
- Pich S, Bach D, Briones P, et al. The Charcot-Marie-Tooth type 2 A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. Hum Mol Genet 14: 1405-1415, 2005.
- (2005) Hum Mol Genet , vol.14 , pp. 1405-1415
- Pich, S.¹ Bach, D.² Briones, P.³

3
- 0021940365
- Improvement of abnormal pyruvate metaboism and cardiac conduction defect with coenzyme Q10 in Kearns-Sayre syndrome
- Ogasahara S, Yorifuji S, Nishikawa Y, et al. Improvement of abnormal pyruvate metaboism and cardiac conduction defect with coenzyme Q10 in Kearns-Sayre syndrome. Neurology 35: 372-377, 1985.
- (1985) Neurology , vol.35 , pp. 372-377
- Ogasahara, S.¹ Yorifuji, S.² Nishikawa, Y.³

4
- 0036218927
- Rapid visual recovery after coenzyme q10 treatment of leber hereditary optic neuropathy
- Huang CC, Kuo HC, Chu CC, Kao LY. Rapid visual recovery after coenzyme q10 treatment of leber hereditary optic neuropathy. J Neuroophthalmol 22: 66, 2002.
- (2002) J Neuroophthalmol , vol.22 , pp. 66
- Huang, C.C.¹ Kuo, H.C.² Chu, C.C.³ Kao, L.Y.⁴

5
- 64049113767
- Coenzyme Q10 in the human retina
- Qu J, Kaufman Y, Washington I. Coenzyme Q10 in the human retina. Invest Ophthalmol Vis Sci 50: 1814-1818, 2009.
- (2009) Invest Ophthalmol Vis Sci , vol.50 , pp. 1814-1818
- Qu, J.¹ Kaufman, Y.² Washington, I.³

6
- 0026340039
- Is Parkinson's disease a mitochondrial disorder?
- Nakagawa-Hattori Y, Yoshino H, Kondo T, Mizuno Y, Horai S. Is Parkinson's disease a mitochondrial disorder? J Neurol Sci 107: 29-33, 1992.
- (1992) J Neurol Sci , vol.107 , pp. 29-33
- Nakagawa-Hattori, Y.¹ Yoshino, H.² Kondo, T.³ Mizuno, Y.⁴ Horai, S.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.